Su-induced arterial hypertension has also been related to an increase in endothelin-1 (ET-1) levels [9], and the administration with the ET-1 receptor antagonist macitentan showed attenuation in the elevation of blood pressure [10]. The gene discussed is EDN1; the disease is Hypertension.